20122 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating; Coating materials Organic compounds, e.g. fats
Sub-classes:MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE
#2SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME
#3CAFFEINE SUSTAINED RELEASE FORMULATION
#4ENTERIC COATED TABLET WITH ACECLOFENAC AND PARACETAMOL TABLET AND PROCESS OF PREPARATION THEREOF
#5VARENICLINE FORMULATIONS
#6COMPOSITIONS WITH REDUCED NITROSAMINE IMPURITIES
#7NOVEL FORMULATIONS AND VEHICLES
#8SACCHARIDE SUSTAINED-RELEASE COMPOSITION AND PREPARATION METHOD THEREOF
#9METHYLPHENIDATE MODIFIED RELEASE FORMULATIONS
#10PHARMACEUTICAL COMPOSITIONS AND METHODS
#11USE OF CO-PROCESSED EXCIPIENTS IN CONTINUOUS MANUFACTURING OF SOLID DOSAGE FORMS
#12LARAZOTIDE FORMULATIONS
#13A SOLID PHARMACEUTICAL COMPOSITION
#14Therapeutic Composition and Methods
#15CONTROLLED RELEASE COMPOSITION AND METHOD
#16SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFEN
#17PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS
#18Improved Thiopurine Formulation and Treatment Methods
#19Obicetrapib and SGLT2 Inhibitor Combination
#20FORMULATIONS OF MAZINDOL
#21Therapeutic Composition and Methods
#22Steroidal Compositions and Method of Making and Use
#23FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS
#24COMPOSITIONS FOR DELIVERY OF REBOXETINE
#25Monomethylfumarate Prodrug Compositions
#26SUPPLEMENTAL COATING AND RELATED METHOD
#27FORMULATIONS FOR SMALL INTESTINAL DELIVERY
#28PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME
#29COMPOSITIONS AND METHODS FOR TREATMENT OF IMMUNE CHECKPOINT RESISTANT CANCERS
#30PHARMACEUTICAL COMPOSITIONS OF OZANIMOD
#31EXTENDED RELEASE COMPOSITIONS COMPRISING PYRIDOSTIGMINE
#32DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#33GEL FILM AND ORAL SOLID COMPOSITION
#34Solid Dosage Form
#35AQUEOUS COMPOSITION COMPRISING HYDROXYPROPYL METHYL CELLULOSE ACETATE SUCCINATE AND METHOD FOR PRODUCING SOLID PREPARATION
#36TASTE MASKED COMPOSTIONS OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND ORALLY DISENTEGRATING TABLET COMPRISING THE SAME
#37SLEEP-REGULATING TABLET ALLOWING RELEASE BY STAGES AND PREPARATION METHOD THEREOF
#38Compounds for treating coronavirus infection
#39EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION
#40ORAL GRANULES WITH COMBINATION OF EXTENDED-RELEASE AND QUICK-RELEASE MAGNESIUM, AND PRODUCTION METHODS
#41PHARMACEUTICAL FORMULATIONS
#42Therapeutic composition and methods
#43Methods and compositions for treating retina-associated disease using CCR3-inhibitors
#44HIGH OPACITY COATINGS AND SUBSTRATES COATED THEREWITH
#45PHARMACEUTICAL COMPOSITION
#46ORALLY DISPERSIBLE COMPOUND CONTAINING AN ESTER OR SALT OF N-BUTYRIC ACID AND PROCESS FOR PRODUCTION
#47ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID
#48BRAIN HEALTH SUPPLEMENTS
#49SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL EXTRACELLULAR VESICLES
#50Pharmaceutical composition and use thereof
#51DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#52SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS
#53OSMOTIC DRUG DELIVERY SYSTEM
#54EXTENDED RELEASE COMPOSITIONS OF PSEUDOEPHEDRINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#55TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#56Steroidal compositions and method of making and use
#57PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#58FORMULATIONS OF MAZINDOL
#59COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF
#60DOSAGE FORM COATING COMPOSITION AND METHOD OF MAKING AND USING THE SAME
#61SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY
#62NEW FORMULATIONS
#63Tesofensine and beta blocker combination formulations
#64Therapeutic composition and methods
#65GRAPE SEED EXTRACTS FOR USE IN THE PREVENTION OR REDUCTION OF STRESS
#66CONTROLLED RELEASE COMPOSITION AND METHOD
#67CHOLINE BOLUS COMPOSITIONS FOR RUMINANTS
#68CONTROLLED RELEASE TOFACITINIB COMPOSITIONS
#69VETERINARY FORMULATIONS COMPRISING RAPAMYCIN AND METHODS OF USING THE SAME FOR TREATING ANIMAL DISEASE
#70Compounds for treating corona virus infection
#71Formulations for small intestinal delivery of RSV and norovirus antigens
#72DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#73Solid oral dosage form of irinotecan for the treatment of cancer
#74TREATMENT OF TAUOPATHIES
#75LARAZOTIDE FORMULATIONS
#76Solid Dosage Form
#77COMPOSITIONS AND METHODS FOR TREATMENT OF IMMUNE CHECKPOINT RESISTANT CANCERS
#78Compositions for delivery of reboxetine
#79METHODS OF USING RIFAMYCIN SV FOR THE TREATMENT OF SICKLE CELL DISEASE
#80RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
#81PHARMACEUTICAL COMPOSITION FOR TREATING LEVODOPA-INDUCED DYSKINESIA OR FOR SUP-PRESSING PROGRESSION THEREOF
#82MONOMETHYLFUMARATE PRODRUG COMPOSITIONS
#83PHARMACEUTICAL COMPOSITIONS COMPRISING GRANULATED BEMPEDOIC ACID
#84Steroidal compositions and method of making and use
#85COMPOSITIONS OF FILM COATINGS FOR TABLETS WITH INCREASED GLOSS, METHOD FOR PRODUCTION THEREOF AND APPLICATION OF SAME
#86PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HAVING DOUBLE-RELEASE PROFILE
#87DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF
#88Sustained release compositions of endoxifen
#89COMPOSITIONS COMPRISING ALGAE POWDER AND USES THEREOF
#90Soft Chewable Pharmaceutical Products
#91PRESSURIZED METERED DOSE INHALERS AND METHOD OF MANUFACTURE
#92PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR
#93FORMULATIONS OF CYCLOSERINE COMPOUNDS AND APPLICATIONS THEREOF
#94STABLE BENZIMIDAZOLE FORMULATION
#95METHOD OF CHEMICAL TAGGING OF TABLETS USING THE COATING
#96Smooth high solids film coating composition comprising water soluble cellulose ether, process for preparing the same and method of use thereof
#97RHEOLOGICAL SOLID ORAL COMPOSITION
#98COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS
#99CONTROLLED RELEASE DOSAGE FORMS OF 5-AMINOSALICYLIC ACID AND PROCESS THEREOF
#100TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#101STEROIDAL COMPOSITIONS AND METHOD OF MAKING AND USE
#102STEROIDAL COMPOSITIONS AND METHOD OF MAKING AND USE
#103Edible functional coatings and hybrid polymer-based coatings for pharmacy and food
#104DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#1055-thiazolecarboxamide kinase inhibitor and uses thereof
#106Solid oral pharmaceutical compositions for isoxazoline compounds
#107Combination dosage form of a mu opioid receptor antagonist and an opioid agent
#108Combinations of beta-lactam compounds and probenecid and uses thereof
#109OXYCODONE AND METHYLNALTREXONE MULTIPARTICULATES AND SUSPENSIONS CONTAINING THEM
#110DOSAGE FORM COATING COMPOSITION AND METHOD OF MAKING AND USING THE SAME
#111COATING COMPOSITION, ORAL SOLID PREPARATION, AND METHOD FOR PRODUCING THE ORAL SOLID PREPARATION
#112Methods and compositions for treating retina-associated disease using CCR3-inhibitors
#113Pharmaceutical composition comprising eluxadoline, process of preparation and use thereof
#114Pharmaceutical Formulations
#115ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#116Composition for use in the treatment of intestinal alterations
#117Method for reducing zoonotic infectious diseases
#118Avoiding gag reflex to enable swallowing pills
#119EFFERVESCENT POWDER DELIVERY SYSTEM
#120Pharmaceutical composition and administrations thereof
#121Tesofensine and beta blocker combination formulations
#122Extended-release pharmaceutical composition containing lacosamide
#123Aqueous enteric coating composition
#124FILMS AND COMPOSITES AND METHODS OF PRODUCTION AND USE
#125CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION
#126Edible Functional Coatings And Hybrid Polymer-Based Coatings For Pharmacy And Food
#127Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
#128Avoiding gag reflex to enable swallowing pills
#129SUPPLEMENT TABLET AND PACKAGING
#130OSMOTIC DRUG DELIVERY SYSTEM
#131COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF
#132TESTOSTERONE UNDECANOATE COMPOSITIONS
#133Therapeutic composition and methods
#134Tesofensine and beta blocker combination formulations
#135PHARMACEUTICAL COMPOSITION
#136Formulations of cysteamine and cystamine
#137Formulations of cycloserine compounds and applications thereof
#138LIPOSOMAL ENCAPSULATION METHOD AND DEVICES
#139DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
#140Immediate release tablet of a benzothiophene compound
#141Composition for use in the treatment of intestinal alterations
#142Therapeutic composition and methods
#143Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds
#144COMPOSITIONS FOR DELIVERY OF REBOXETINE
#145OSMOTIC DRUG DELIVERY SYSTEM
#146Combination dosage form of a mu opioid receptor antagonist and an opioid agent
#147Film coating composition and methods of making and using the same
#148Calcium alginate dosage formulations, and methods of making and using thereof
#149Compositions and methods for reducing overdose
#150Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof
#151Monomethylfumarate Prodrug Compositions
#152PHARMACEUTICAL COMPOSITIONS
#153Controlled release and taste masking oral pharmaceutical composition
#154Soft chewable pharmaceutical products
#155ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#156PHARMACEUTICAL MATRIX FORMULATIONS COMPRISING DIMETHYL FUMARATE
#157COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#158CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS
#159COMPOSITIONS BASED ON PLANT EXTRACTS FOR INHIBITION OF THE 5-ALPHA REDUCTASE
#160Method of treatment using nanoparticulate ganaxolone formulations
#161GANAXOLONE FORMULATION AND USE THEREOF
#162Soft Chewable Pharmaceutical Product
#163Soft Chewable Pharmaceutical Products
#164Galenic formulations of organic compounds
#165PHARMACEUTICAL MATRIX FORMULATIONS COMPRISING DIMETHYL FUMARATE
#166Controlled release delivery device comprising an organosol coat
#167CONTROLLED RELEASE COMPOSITIONS FOR TREATMENT OF COGNITIVE, EMOTIONAL, AND MENTAL AILMENTS AND DISORDERS
#168Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
#169Controlled release and taste masking oral pharmaceutical composition
#170Carvedilol Immediate Release Formulation Having Improved Madescent
#171Film-forming compositions for the film-coating of solid forms
#172CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS
#173CONTROLLED RELEASE HYDROCODONE FORMULATIONS
#174Extended, delayed and immediate release formulation method of manufacturing and use thereof
#175CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS
#176Controlled release and taste masking oral pharmaceutical composition
#177Pharmaceutical formulations of a HIF hydroxylase inhibitor
#178Solid oral dosage form of irinotecan for the treatment of cancer
#179Tesofensine and beta blocker combination formulations
#180CONTROLLED RELEASE COMPOSITION AND METHOD
#181FIXED DOSE FORMULATIONS
#182Controlled release and taste masking oral pharmaceutical composition
#183BIODEGRADABLE COATINGS AND PAINTS
#184DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#185STABLE BENZIMIDAZOLE FORMULATION
#186COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS
#187Film-forming compositions based on starchy material and articles obtained thereof
#188Tablet
#189Pressurized metered dose inhalers and method of manufacture
#190COMPOSITIONS FOR ILEO-JEJUNAL DRUG DELIVERY
#191MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#192COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#193Formulations for small intestinal delivery of RSV and norovirus antigens
#194Modified-release therapeutic systems for oral administration of curcumin in the treatment of intestinal disorders
#195Modified-release therapeutic systems for oral administration of menthol in the treatment of intestinal disorders
#196Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection
#197TESTOSTERONE UNDECANOATE COMPOSITIONS
#198ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
#199Production of pharmaceutical protective coatings with good resistance in a neutral environment
#200DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
#201Tesofensine, beta blocker combination formulation
#202Combination dosage form of a mu opioid receptor antagonist and an opioid agent
#203Easy to swallow coatings and substrates coated therewith
#204Compositions and methods for treating metabolic disorders
#205Tablets comprising GLP-1 agonist and enteric coating
#206MODIFIED RELEASE COMPOSITIONS OF EPALRESTAT OR A DERIVATIVE THEREOF AND METHODS FOR USING THE SAME
#207NANOPARTICLES FOR LIPID HOMEOSTASIS
#208Enteric Film Coating Compositions, Method of Coating, and Coated Forms
#209Press coated tablet prepared for delayed release of an active ingredient
#210BILAYER TABLET FORMULATIONS
#211METHOD OF TREATING HYPERTENSION
#212METHODS AND COMPOSITION FOR TREATMENT OF CARDIOVASCULAR CONDITIONS
#213EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF
#214EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF
#215Controlled release and taste masking oral pharmaceutical compositions
#216Controlled release and taste masking oral pharmaceutical compositions
#217Controlled release and taste masking oral pharmaceutical composition
#218Soft chewable pharmaceutical products
#219ENHANCER FOR EATING ACTIVITY AND/OR GASTROINTESTINAL ACTIVITY
#220Film coating composition and methods of making and using the same
#221Compositions and methods for reducing overdose
#222Pharmaceutical composition of rosuvastatin calcium
#223FORMULATIONS FOR SMALL INTESTINAL DELIVERY
#224Direct compression polymer tablet core
#225Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate
#226Composition and method for reducing zoonotic infectious diseases
#227Nicotine-Containing Solid Oral Formulations and Uses Thereof
#228Compositions and methods for reducing overdose
#229Easily dosable solid preparation
#230Controlled release and taste masking oral pharmaceutical compositions
#231Methods of manufacturing oral dosage forms
#232DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
#233CARBIDOPA/LEVODOPA GASTRORETENTIVE DRUG DELIVERY
#234Controlled release delivery device comprising an organosol coat
#235COMPOSITIONS BASED ON PLANT EXTRACTS FOR INHIBITION OF THE 5-ALPHA REDUCTASE
#236PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT 5-METHYL-1-PHENYL-2-(1H)-PYRIDONE
#237Solid dosage forms of bendamustine
#238Pharmaceutical composition and administrations thereof
#239Compositions and methods for reducing overdose
#240Compositions and methods for reducing overdose
#241Controlled release and taste masking oral pharmaceutical composition
#242Alcohol-Resistant, Dose Dumping Protective Enteric Drug Film Coating
#243SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB
#244Calcium alginate dosage formulations, and methods of making and using thereof
#245Immediate release film coatings containing medium chain glycerides and substrates coated therewith
#246Film coated tablet containing choline alfoscerate and process for preparing the same
#247Controlled-release solid preparation with partial coating
#248MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#249Pressurised metered dose inhalers and method of manufacture
#250Organic Compounds
#251Solid oral dosage form of irinotecan for the treatment of cancer
#252Coated solid dosage forms
#253AQUEOUS ENTERIC COATING COMPOSITION
#254Controlled release and taste masking oral pharmaceutical composition
#255DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#256COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN OPIOID AGENT
#257Multilayer solid pharmaceutical dosage forms
#258Slow-release solid oral compositions
#259Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection
#260Tesofensine and beta blocker combination formulations
#261Osmotic drug delivery system
#262Delayed release tablet with defined core geometry
#263COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS
#264Controlled release hydrocodone formulations
#265MONOMETHYLFUMARATE PRODRUG COMPOSITIONS
#266PHARMACEUTICAL COMPOSITIONS CONTAINING REFAMETINIB
#267PHARMACEUTICAL COMPOSITION AND USES THEREOF
#268Compositions and methods for treating metabolic disorders
#269Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone
#270PULSATILE GASTRIC RETENTIVE DOSAGE FORMS
#271Dissolution stability of calcium carbonate tablets
#272Cabozantinib dosage form and use in the treatment of cancer
#273Compositions and methods for reducing overdose
#274Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
#275Extended, delayed and immediate release formulation method of manufacturing and use thereof
#276Pharmaceutical products
#277HIGH DRUG LOAD PHARMACEUTICAL COMPOSITIONS WITH CONTROLLABLE RELEASE RATE AND PRODUCTION METHODS THEREOF
#278Solid ganaxolone compositions and methods for the making and use thereof
#279Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
#280Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof
#281CONTROLLED RELEASE COMPOSITION AND METHOD
#282Stable pharmaceutical compositions of saxagliptin or salts thereof
#283Bilayer tablet formulations
#284Controlled release hydrocodone formulations
#285Controlled release hydrocodone formulations
#286PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT 5-METHYL -1-PHENYL-2-(1H)-PYRIDONE
#287Immediate release film coatings containing medium chain glycerides and substrates coated therewith
#288Solid oral pharmaceutical compositions for isoxazoline compounds
#289Direct compression polymer tablet core
#290Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof
#291Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
#292STABLIZED MODIFIED RELEASE FOLIC ACID DERIVATIVE COMPOSITION, ITS THERAPEUTIC USE AND METHODS OF MANUFACTURE
#293Testosterone undecanoate compositions
#294Controlled release and taste masking oral pharmaceutical composition
#295Controlled release hydrocodone formulations
#296Formulation for providing an enteric coating material
#297ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#298Pharmaceutical compositions comprising renewably-based biodegradable 1,3-propanediol
#299Delayed release tablet with defined core geometry
#300Agricultural compositions comprising renewably-based biodegradable 1,3-propanediol